Logo image of CCAP

CRESCENT CAPITAL BDC INC (CCAP) Stock Fundamental Analysis

NASDAQ:CCAP - Nasdaq - US2256551092 - Common Stock - Currency: USD

14.31  +0.12 (+0.85%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CCAP. CCAP was compared to 237 industry peers in the Capital Markets industry. There are concerns on the financial health of CCAP while its profitability can be described as average. CCAP is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CCAP was profitable.
CCAP had a positive operating cash flow in the past year.
CCAP had positive earnings in each of the past 5 years.
In multiple years CCAP reported negative operating cash flow during the last 5 years.
CCAP Yearly Net Income VS EBIT VS OCF VS FCFCCAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M

1.2 Ratios

CCAP has a Return On Assets of 2.97%. This is comparable to the rest of the industry: CCAP outperforms 54.01% of its industry peers.
The Return On Equity of CCAP (6.81%) is comparable to the rest of the industry.
CCAP has a Return On Invested Capital (4.07%) which is in line with its industry peers.
Industry RankSector Rank
ROA 2.97%
ROE 6.81%
ROIC 4.07%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CCAP Yearly ROA, ROE, ROICCCAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

CCAP has a better Profit Margin (26.20%) than 68.35% of its industry peers.
CCAP's Profit Margin has declined in the last couple of years.
CCAP has a better Operating Margin (44.43%) than 78.06% of its industry peers.
In the last couple of years the Operating Margin of CCAP has declined.
CCAP has a Gross Margin of 46.29%. This is comparable to the rest of the industry: CCAP outperforms 48.95% of its industry peers.
CCAP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 44.43%
PM (TTM) 26.2%
GM 46.29%
OM growth 3Y-4.73%
OM growth 5Y-5.04%
PM growth 3Y-25.14%
PM growth 5Y-7.39%
GM growth 3Y-5.55%
GM growth 5Y-5.93%
CCAP Yearly Profit, Operating, Gross MarginsCCAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CCAP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CCAP Yearly Shares OutstandingCCAP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CCAP Yearly Total Debt VS Total AssetsCCAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

CCAP has an Altman-Z score of 0.40. This is a bad value and indicates that CCAP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CCAP (0.40) is worse than 67.09% of its industry peers.
The Debt to FCF ratio of CCAP is 210.82, which is on the high side as it means it would take CCAP, 210.82 years of fcf income to pay off all of its debts.
CCAP has a Debt to FCF ratio (210.82) which is comparable to the rest of the industry.
CCAP has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
CCAP has a Debt to Equity ratio of 1.24. This is in the lower half of the industry: CCAP underperforms 60.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 210.82
Altman-Z 0.4
ROIC/WACCN/A
WACCN/A
CCAP Yearly LT Debt VS Equity VS FCFCCAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

CCAP has a Current Ratio of 0.34. This is a bad value and indicates that CCAP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.34, CCAP is doing worse than 82.70% of the companies in the same industry.
CCAP has a Quick Ratio of 0.34. This is a bad value and indicates that CCAP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CCAP (0.34) is worse than 82.70% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
CCAP Yearly Current Assets VS Current LiabilitesCCAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

3

3. Growth

3.1 Past

CCAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.51%.
Measured over the past 5 years, CCAP shows a small growth in Earnings Per Share. The EPS has been growing by 7.26% on average per year.
Looking at the last year, CCAP shows a decrease in Revenue. The Revenue has decreased by -3.11% in the last year.
CCAP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.83% yearly.
EPS 1Y (TTM)-11.51%
EPS 3Y10.16%
EPS 5Y7.26%
EPS Q2Q%-40.79%
Revenue 1Y (TTM)-3.11%
Revenue growth 3Y28.05%
Revenue growth 5Y29.83%
Sales Q2Q%-16.35%

3.2 Future

CCAP is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -14.62% yearly.
Based on estimates for the next years, CCAP will show a decrease in Revenue. The Revenue will decrease by -8.51% on average per year.
EPS Next Y-26.65%
EPS Next 2Y-17.81%
EPS Next 3Y-14.62%
EPS Next 5YN/A
Revenue Next Year-15.39%
Revenue Next 2Y-10.61%
Revenue Next 3Y-8.51%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCAP Yearly Revenue VS EstimatesCCAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
CCAP Yearly EPS VS EstimatesCCAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.42, the valuation of CCAP can be described as very cheap.
Based on the Price/Earnings ratio, CCAP is valued cheaply inside the industry as 92.41% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.54. CCAP is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 8.34, the valuation of CCAP can be described as reasonable.
Based on the Price/Forward Earnings ratio, CCAP is valued cheaply inside the industry as 84.39% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.28, CCAP is valued rather cheaply.
Industry RankSector Rank
PE 6.42
Fwd PE 8.34
CCAP Price Earnings VS Forward Price EarningsCCAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CCAP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 123.82
EV/EBITDA N/A
CCAP Per share dataCCAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CCAP's earnings are expected to decrease with -14.62% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.88
EPS Next 2Y-17.81%
EPS Next 3Y-14.62%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.87%, CCAP is a good candidate for dividend investing.
CCAP's Dividend Yield is a higher than the industry average which is at 8.25.
Compared to an average S&P500 Dividend Yield of 2.40, CCAP pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.87%

5.2 History

CCAP has been paying a dividend for over 5 years, so it has already some track record.
CCAP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years4
Div Non Decr Years4
CCAP Yearly Dividends per shareCCAP Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

148.85% of the earnings are spent on dividend by CCAP. This is not a sustainable payout ratio.
DP148.85%
EPS Next 2Y-17.81%
EPS Next 3Y-14.62%
CCAP Yearly Income VS Free CF VS DividendCCAP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M
CCAP Dividend Payout.CCAP Dividend Payout, showing the Payout Ratio.CCAP Dividend Payout.PayoutRetained Earnings

CRESCENT CAPITAL BDC INC

NASDAQ:CCAP (8/8/2025, 12:05:49 PM)

14.31

+0.12 (+0.85%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-13 2025-08-13
Inst Owners49.5%
Inst Owner Change-0.39%
Ins Owners1.14%
Ins Owner Change0%
Market Cap530.33M
Analysts83.33
Price Target17.68 (23.55%)
Short Float %0.46%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield 11.87%
Yearly Dividend1.9
Dividend Growth(5Y)N/A
DP148.85%
Div Incr Years4
Div Non Decr Years4
Ex-Date08-29 2025-08-29 (0.05)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.1%
Min EPS beat(2)-15.91%
Max EPS beat(2)-4.28%
EPS beat(4)1
Avg EPS beat(4)-2.74%
Min EPS beat(4)-15.91%
Max EPS beat(4)9.46%
EPS beat(8)5
Avg EPS beat(8)2.86%
EPS beat(12)7
Avg EPS beat(12)2.91%
EPS beat(16)11
Avg EPS beat(16)3.99%
Revenue beat(2)0
Avg Revenue beat(2)-6.07%
Min Revenue beat(2)-8.38%
Max Revenue beat(2)-3.76%
Revenue beat(4)2
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-8.38%
Max Revenue beat(4)3.96%
Revenue beat(8)5
Avg Revenue beat(8)-0.45%
Revenue beat(12)7
Avg Revenue beat(12)0.44%
Revenue beat(16)9
Avg Revenue beat(16)1.13%
PT rev (1m)0%
PT rev (3m)-10.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.45%
Valuation
Industry RankSector Rank
PE 6.42
Fwd PE 8.34
P/S 2.8
P/FCF 123.82
P/OCF 123.82
P/B 0.73
P/tB 0.73
EV/EBITDA N/A
EPS(TTM)2.23
EY15.58%
EPS(NY)1.72
Fwd EY11.99%
FCF(TTM)0.12
FCFY0.81%
OCF(TTM)0.12
OCFY0.81%
SpS5.1
BVpS19.62
TBVpS19.62
PEG (NY)N/A
PEG (5Y)0.88
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 6.81%
ROCE 5.15%
ROIC 4.07%
ROICexc 4.1%
ROICexgc 4.12%
OM 44.43%
PM (TTM) 26.2%
GM 46.29%
FCFM 2.26%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.73%
OM growth 5Y-5.04%
PM growth 3Y-25.14%
PM growth 5Y-7.39%
GM growth 3Y-5.55%
GM growth 5Y-5.93%
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 210.82
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.47
Cash Conversion N/A
Profit Quality 8.64%
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z 0.4
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)123.47%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.51%
EPS 3Y10.16%
EPS 5Y7.26%
EPS Q2Q%-40.79%
EPS Next Y-26.65%
EPS Next 2Y-17.81%
EPS Next 3Y-14.62%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.11%
Revenue growth 3Y28.05%
Revenue growth 5Y29.83%
Sales Q2Q%-16.35%
Revenue Next Year-15.39%
Revenue Next 2Y-10.61%
Revenue Next 3Y-8.51%
Revenue Next 5YN/A
EBIT growth 1Y-6.46%
EBIT growth 3Y21.99%
EBIT growth 5Y23.29%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.94%
OCF growth 3YN/A
OCF growth 5YN/A